Login
Register
Reset Password
Publish & Distribute
Publishing Solutions
Distribution Solutions
Subjects
Architecture and Design
Arts
Business and Economics
Chemistry
Classical and Ancient Near Eastern Studies
Computer Sciences
Cultural Studies
Engineering
General Interest
Geosciences
History
Industrial Chemistry
Jewish Studies
Law
Library and Information Science, Book Studies
Life Sciences
Linguistics and Semiotics
Literary Studies
Materials Sciences
Mathematics
Medicine
Music
Pharmacy
Philosophy
Physics
Social Sciences
Sports and Recreation
Theology and Religion
Publications
Journals
Books
Proceedings
Publishers
Blog
Contact
Search
EUR
USD
GBP
English
English
Deutsch
Polski
Español
Français
Italiano
Cart
Home
Journals
Radiology and Oncology
Volume 47 (2013): Issue 1 (March 2013)
Open Access
Epirubicin and docetaxel as neoadjuvant treatment of hormone receptor positive, HER-2 negative breast cancer: findings from two successive phase II studies
Alessandro Tuzi
Alessandro Tuzi
,
Davide Lombardi
Davide Lombardi
,
Diana Crivellari
Diana Crivellari
,
Loredana Militello
Loredana Militello
,
Tiziana Perin
Tiziana Perin
,
Manuela La Grassa
Manuela La Grassa
,
Samuele Massarut
Samuele Massarut
and
Andrea Veronesi
Andrea Veronesi
| Feb 01, 2013
Radiology and Oncology
Volume 47 (2013): Issue 1 (March 2013)
About this article
Previous Article
Next Article
Abstract
References
Authors
Articles in this Issue
Preview
PDF
Cite
Share
Published Online:
Feb 01, 2013
Page range:
57 - 62
DOI:
https://doi.org/10.2478/raon-2013-0012
Keywords
breast cancer
,
docetaxel
,
epirubicin
,
neoadjuvant chemotherapy
This content is open access.